Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$7.03 -0.28 (-3.90%)
As of: Oct 21, 2026 · 3:59 PM EDT

Phathom Pharmaceuticals (PHAT) Long-Term Debt Repayments (2026)

Updated

Phathom Pharmaceuticals' Long-Term Debt Repayments was $229.05 million in Q1 2026.

Analysis

Phathom Pharmaceuticals (PHAT) Long-Term Debt Repayments (2026) Analysis & Trends

For FY2021, Long-Term Debt Repayments at Phathom Pharmaceuticals came in at $54.13 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Phathom Pharmaceuticals 587.90 Mn -52.05 Mn 59.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 229.05 Mn
API Access

Phathom Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=PHAT&period=max&api_key=YOUR_API_KEY